Given that candidate mutations in both FMRP targets and PSD genes are present at a significantly greater frequency in individuals with schizophrenia compared to typically developing controls [15–17], these results suggest that reduced levels of CYFIP1 might increase risk for schizophrenia at least in part through dysregulation of one or both of these functional networks. This evidence concerns the gene PSD and schizophrenia.